Hereditary Sensory and Autonomic Neuropathies: Adding More to the Classification

Area of Science:

• Neurology
• Genetics
• Rare Diseases

Background:

• Hereditary Sensory and Autonomic Neuropathies (HSAN) are a diverse group of inherited disorders.
• These conditions are characterized by significant sensory and autonomic nervous system dysfunction.
• Classification relies on inheritance patterns, genetic mutations, and clinical presentation.

Purpose of the Study:

• To review recent updates in HSAN classification.
• To discuss current management strategies, including novel disease-modifying agents.
• To highlight the role of genetic testing in diagnosis and precision medicine.

Main Methods:

• Review of recent scientific literature on HSAN.
• Analysis of newly identified HSAN types and their associated genotypes.
• Examination of ongoing clinical trials for HSAN therapeutics.

Main Results:

• Three new HSAN types have been added in the last decade, expanding genotype-phenotype diversity.
• Clinical trials are actively investigating disease-modifying and symptomatic treatments, particularly for HSAN type III.
• Genetic testing is crucial for accurate diagnosis and tailored patient management.

Conclusions:

• The growing diversity of HSAN necessitates updated classification and management approaches.
• Precision medicine, driven by genetic insights, holds promise for targeted HSAN treatments.
• Continued research into HSAN pathophysiology is essential for developing effective therapies.